-+ 0.00%
-+ 0.00%
-+ 0.00%

ARS Pharmaceuticals FY2025 net product revenue rose 895% to USD 72.19 million as net loss widened to USD 171.3 million

Reuters·03/09/2026 10:00:52

Please log in to view news